Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of MPNs

Release Date: December 30, 2018
Expiration Date: December 30, 2019
Media: Internet - based

Activity Overview

This program, Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of MPNs, covers 6 of the most important and clinically relevant poster presentations and abstracts presented at the 60th Annual American Society of Hematology (ASH) Meeting and Exposition in San Diego, CA. This program discusses key aspects of the design, efficacy, and safety readouts of key clinical studies evaluating treatment strategies across the myeloproliferative neoplasms (MPNs). In this program, you will learn the latest practice patterns in the field in MPNs, as well as the latest strategies for predicting risk based on patient clinical and genetic features in myelofibrosis (MF). Commentaries from 2 world-renowned experts in MPNs, Srdan Verstovsek, MD, PhD, of the MD Anderson Cancer Center, and Ruben Mesa, MD, of Mays Cancer Center, associated with UT Health San Antonio. Physicians will contextualize the clinical relevance of study findings throughout the program.

Benefits of participating:

  • Learn key aspects of the latest studies on MPNs from the ASH annual meeting
  • Get an update on the latest practice patterns in MPNs
  • Gain insight into the latest strategies for MF risk prediction

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical oncologists/hematologists and fellows who treat patients with myeloproliferative neoplasms. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of MPNs are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Detail the design, efficacy, and safety readouts of completed and ongoing clinical studies in patients with PV, ET, and MF
  • Explain recent clinical trial results regarding novel compounds and strategies for patients with PV, ET, and MF
  • Place presented trial evidence into the context of evolving treatment paradigms and strategies in the management of patients with MPNs.

Faculty, Staff, and Planners' Disclosures


Ruben A. Mesa
Ruben A. Mesa, MD, FACP
Director, Mays Cancer Center
Mays Family Foundation Distinguished University Presidential Chair
Professor of Medicine
UT Health San Antonio MD Anderson Cancer Center
Houston, TX

Disclosures: Grant/Research Support: Celgene, Genentech, Incyte, CTI; Consultant: Novartis, La Jolla Pharma, Sierra Oncology

Srdan Verstovsek
Srdan Verstovsek, MD, PhD
Professor of Medicine
Chief, Section for Myeloproliferative Neoplasms (MPNs)
Director, Hanns A. Pielenz Clinical Research Center for MPNs
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant/Research Support: Incyte Corporation, Roche, AstraZeneca, Lilly Oncology, NS Pharma, Bristol-Myers Squibb, Celgene, Gilead, Seattle Genetics, Promedior, CTI BioPharma Corp, Galena BioPharma, Pfizer, Genentech, Blueprint Medicines Corp

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By